AND017
AND017 is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
Clinical Trials (6)
A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
A Food-Effect Study of AND017 in Healthy Participants
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6